May 15, 2013 University of Chicago launches cloud to analyze cancer data The University of Chicago is launching the first secure cloud - based computing system that will enable researchers to access and analyze
human genomic cancer information without the costly and cumbersome infrastructure normally needed to download and store massive amounts of data.
Not exact matches
Sir John Bell, professor of medical sciences at Oxford University and government advisor on
human genomics believes this will transform
cancer treatment in the UK.
The U.S. National Institutes of Health (NIH) has made major investments in network approaches in many areas, including
cancer biology, cardiovascular and metabolic diseases, neurophysiology, and
human genetics and
genomics.
Using
genomic analysis to study
cancer in dogs can help develop new therapies for humans with cancer, according to a proof - of - concept study led by the National Cancer Institute (NCI) and the Translational Genomics Research Institute (
cancer in dogs can help develop new therapies for
humans with
cancer, according to a proof - of - concept study led by the National Cancer Institute (NCI) and the Translational Genomics Research Institute (
cancer, according to a proof - of - concept study led by the National
Cancer Institute (NCI) and the Translational Genomics Research Institute (
Cancer Institute (NCI) and the Translational Genomics Research Institute (TGen).
Lead author Moustafa Abdalla writes: «Almost all
genomic studies of breast
cancer have focused on well - established tumours because it is technically challenging to study the earliest mutational events occurring in
human breast epithelial cells.»
Tamayo and team tested REVEALER using The
Cancer Genome Atlas (TCGA), the National Institutes of Health's database of genomic information from more than 500 human tumors representing many cancer
Cancer Genome Atlas (TCGA), the National Institutes of Health's database of
genomic information from more than 500
human tumors representing many
cancer cancer types.
«So perhaps in this age of
cancer genomics showing how diverse and heterogenous
human cancer is, we should be focusing on the common effects that different mutations lead to,» he says.
The study analyzed data from The
Cancer Genome Atlas (TCGA), a research program supported by the National Cancer Institute and National Human Genome Research Institute within the National Institutes of Health that is looking at genomic changes in more than 20 different types of c
Cancer Genome Atlas (TCGA), a research program supported by the National
Cancer Institute and National Human Genome Research Institute within the National Institutes of Health that is looking at genomic changes in more than 20 different types of c
Cancer Institute and National
Human Genome Research Institute within the National Institutes of Health that is looking at
genomic changes in more than 20 different types of
cancercancer.
The
Cancer, Ageing and Somatic Mutation Programme encompasses three Projects that respectively cover the genomics of human cancers; functional analysis of the cancer genome using a range of in vitro and in vivo model systems; and the characterisation of somatic mutations in development and adult homeostasis in health and di
Cancer, Ageing and Somatic Mutation Programme encompasses three Projects that respectively cover the
genomics of
human cancers; functional analysis of the
cancer genome using a range of in vitro and in vivo model systems; and the characterisation of somatic mutations in development and adult homeostasis in health and di
cancer genome using a range of in vitro and in vivo model systems; and the characterisation of somatic mutations in development and adult homeostasis in health and disease.
Participating institutions: Helmholtz Association • CNRS • Institute of Molecular Biotechnology • Research Center for Molecular Medicine of the Austrian Academy of Sciences • VIB - KU Leuven • Friedrich Miescher Institute for Biomedical Research • University of Basel • University of Zurich • Central European Institute of Technology • Max Planck Institute of Immunobiology and Epigenetics • Max Planck Institute for Molecular Genetics • German
Cancer Research Center • Max Delbrück Center for Molecular Medicine • German Center for Neurodegenerative Diseases • Helmholtz Zentrum München • Max Planck Institute for Evolutionary Anthropology • Helmholtz Institute of RNA - based Infection Research • Saarland University • Technical University Munich • University of Würzburg • Biotech Research & Innovation Centre • Interdisciplinary Nanoscience Center • University of Copenhagen • Centre for
Genomic Regulation • Institut Curie • Université de Montpellier • Inserm • Université Toulouse III — Paul Sabatier • École nationale supérieure des mines de Paris • Institute for Molecular Medicine Finland • The Biomedical Research Foundation, Academy of Athens • Weizmann Institute of Science • Hebrew University • Sapienza — University of Rome • Instituto Nazionale Genetica Molecolare • University of Napoli • University of Padua • University of Milan • European Institute of Oncology • Netherlands
Cancer Institute • Radboud University • University Medical Center Utrecht • Hubrecht Institute • Instituto Gulbenkian de Ciência • Institute of Bioorganic Chemistry of the Polish Academy of Sciences • Romanian Center for Systems Immunology • Karolinska Institute • MRC
Human Genetics Unit • University of Edinburgh • Wellcome Sanger Institute • The Babraham Institute • European Molecular Biology Laboratory — European Bioinformatics Institute
Major focus areas include
human genome interpretation and genetic dissection of novel rare diseases, predictive
genomic signatures of response to therapy — especially
cancer therapy, and novel sequencing - based assays as biomarkers of disease.
Elected by his peers, Liu was recognized for his distinguished contributions to
cancer biology, particularly the molecular analysis of breast
cancer, and to the global advancement of
human genomics.
Aug 8, 2008 Two New Predisposition Genes For Breast, Thyroid And Kidney
Cancers Could Lead to More Accurate Diagnosis and Earlier Detection of These
Cancers Charis Eng, MD, PhD, Sondra J and Stephen R Hardis Endowed Chair of
Cancer Genomic Medicine and Chair, GMI, and her team published in the Aug 8, 2008 issue of the American Journal of
Human Genetics that germline mutations in SDHB and SDHD, which play key roles in the mitochondria (the cell's power houses), predispose to Cowden and Cowden - like syndromes.
Liu's scientific research focuses on the functional
genomics of
human cancers, particularly breast
cancer, uncovering new oncogenes, and deciphering on a
genomic scale the dynamics of gene regulation that modulate
cancer biology.
The HDCA programme will create
genomic reference maps of all the cells that are important for
human development, which will revolutionise our understanding of health and disease, from miscarriages and children's developmental disorders, through to
cancer and ageing.
His honours and awards include the inaugural Gutenberg Professorship of the University of Strasbourg, the Order of Australia and Australian Government Centenary Medal, Fellowship of the Australian Academy of Science, Associate Membership of the European Molecular Biology Organization, Honorary Fellowship of the Royal College of Pathologists of Australasia, the International Union of Biochemistry & Molecular Biology Medal, the
Human Genome Organisation Chen Award for Distinguished Achievement in
Human Genetic &
Genomic Research, and the University of Texas MD Anderson
Cancer Center Bertner Memorial Award for Distinguished Contributions to
Cancer Research.
Human cancers exhibit a diverse array of
genomic gains and losses that alter the dosage of hundreds of genes at once.
Tags: AACR 2017, aacr 2018, Breast
Cancer, Christopher J Kemp, Clinical Research, Colorectal Cancer, Eddie Mendez, genomics, head neck cancers, Human Biology, Ovarian Cancer, Pancreatic Cancer, precision medicine, Public Health Sciences, solid tumors, uterine cancer, Vijayakrishn
Cancer, Christopher J Kemp, Clinical Research, Colorectal
Cancer, Eddie Mendez, genomics, head neck cancers, Human Biology, Ovarian Cancer, Pancreatic Cancer, precision medicine, Public Health Sciences, solid tumors, uterine cancer, Vijayakrishn
Cancer, Eddie Mendez,
genomics, head neck
cancers,
Human Biology, Ovarian
Cancer, Pancreatic Cancer, precision medicine, Public Health Sciences, solid tumors, uterine cancer, Vijayakrishn
Cancer, Pancreatic
Cancer, precision medicine, Public Health Sciences, solid tumors, uterine cancer, Vijayakrishn
Cancer, precision medicine, Public Health Sciences, solid tumors, uterine
cancer, Vijayakrishn
cancer, Vijayakrishna Gadi
Investigations of this phenomenon may provide unique access to understanding
genomic disorders, structural variant mutagenesis,
human evolution, and
cancer biology.
Laboratory activities minimally include performing a lab - based patient - oriented research project applicable to
cancer genomics, with an emphasis on mastering techniques commonly used within a
human genetics laboratory, such as PCR, gene sequencing, mutation analysis, western blots, and functional protein studies.
Integrative annotation of variants from 1092
humans: application to
cancer genomics.
Massively parallel sequencing (next - generation sequencing) has revolutionized research in
cancer genetics and
genomics [1] and enhanced our understanding of natural
human genetic variation [2], [3].
Examples include the study of allelic variation in the
human genome and the development of computational methods for the discovery of
cancer - associated genes and diagnostic
cancer markers using
genomic profiles derived from different tumor types.
In this session, we will discuss methods for integrated analysis of DNA and RNA and their application in
human genomic research in the areas of
cancer genomics,
human disease research, and regulation of gene expression.
This centre has been devised as a space for excellence research in
genomic medicine, focussing on the comprehensive study and understanding of the genetic basis of
human diseases in general, placing special emphasis on
cancer and its genetic disorders related to inheritance.
Tags:
cancer genomics, Carla Grandori, Christopher J Kemp, Clinical Research, Eddie Mendez, Good News, head neck
cancers,
Human Biology, Jerald P Radich, personalized treatment, precision medicine, Tumor specific translational research, Vijayakrishna Gadi
From our earliest research that established
cancer as a genetic disease to today's work in precision medicine, our unswerving focus on genetics and
genomics continues to generate advances that improve
human health.
Genomic rearrangements are a hallmark of
human cancers.
GENYO is the first national centre devoted to
genomics that integrates the Public Administration, the University and the biotechnology and pharmaceutical business sector, which would allow the integration of research in all its phases, from the generation of knowledge to its development in clinical and pharmaceutical applications, the development of new projects and services for the prevention, diagnosis and treatment of diseases associated to
human genetic variability, such a
cancer and rare diseases, diabetes, hypertension or degenerative diseases, among others.
These molecular subtypes have recently been confirmed in a comprehensive characterization of
human breast tumors at the
genomic, epigenetic, transcriptomic, and proteomic levels (
Cancer Genome Atlas Network, 2012).
Innovative research using comparative
genomics has helped us identify unique molecular signatures that are associated with disease progression and can thus be used to prognosticate and personalize therapies for dogs and
humans with
cancer.
My primary research interests are
human genetics and
cancer genomics, and the content of my blog reflects that.